Nachrichten zur Hims & Hers Health Inc. Aktie

HIMS Expands Offerings for Menopause with Estrogen Patches

On April 22, 2026, Hims & Hers Health Inc (HIMS) announced the launch of a new service aimed at women…

Hims & Hers offers estrogen patches as US demand surges

The telehealth company said it had secured sufficient inventory to allow eligible patients to begin or continue treatment without disruption.…

Hims & Hers says it has steady estrogen patch supply amid US shortages

Telehealth company Hims & Hers NYSE:HIMS said on Wednesday it has a steady supply of estrogen patches and is offering…

Hims & Hers doubles down on estrogen patches as demand surges

Hims & Hers (HIMS) stock is in focus as the company expands offerings to menopause care, with sales of estrogen…

Hims & Hers Stock Sinks as Amazon Crashes Party

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers expands into menopause care as estrogen patch demand rises

Telehealth company Hims & Hers said on Wednesday it will now offer treatment options for perimenopause and menopause via its…

Hims & Hers Health stock price forecast: $25.24 support in focus as HIMS slips 3.83%

Hims & Hers Health trades at $28.62 today, down 3.83%. Stay updated on latest price action, market trends, and support…

A Look At Hims & Hers Health (HIMS) Valuation After Novo Nordisk Deal And GLP 1 Market Shift

Hims & Hers Health (HIMS) is back in focus after renewing its partnership with Novo Nordisk, giving the telehealth platform…

Hims & Hers price target raised to $30 from $25 at BofA

BofA raised the firm’s price target on Hims Hers (HIMS) to $30 from $25 and keeps a Neutral rating…

Is Hims & Hers Health Inc (HIMS) a Bargain After 4.0% Drop? GF Value Says Undervalued

On April 21, 2026, Hims & Hers Health Inc (HIMS) shares fell 4.0%, closing at $29.76. The stock has seen…

Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors

Hims & Hers Health, Inc. (HIMS) reached $29.76 at the closing of the latest trading day, reflecting a -4.03% change…

Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors

Hims & Hers Health, Inc. (HIMS) reached $29.76 at the closing of the latest trading day, reflecting a -4.03% change…

Hims & Hers Stock Slides as Amazon Enters the GLP-1 Weight-Loss Race

Hims & Hers Health shares fell 1.6% to $30.52 Tuesday after Amazon launched a GLP-1 weight-management program through One Medical,…

Why Is Hims & Hers Health Stock Falling Tuesday? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers stock falls as Amazon launches a weight loss program with integrated care, pricing options, and nationwide delivery.…

Why Hims & Hers Stock Is Slumping Today

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers builds scalable data-driven personalized care platform

Hims & Hers Health, Inc. HIMS has increasingly positioned itself at the intersection of healthcare and data, building a platform…

Hims & Hers Builds Scalable Data-Driven Personalized Care Platform

Hims & Hers Health, Inc. HIMS has increasingly positioned itself at the intersection of healthcare and data, building a platform…

Hims & Hers stock soars 49%: 5 things driving the rally

Hims & Hers stock climbed 49% in five days after the FDA signaled peptide relief and Novo Nordisk settled its…

Hims & Hers Health stock falls after Amazon launches GLP-1 program

Hims & Hers Health stock falls after Amazon launches GLP-1 program…

Hims & Hers Health stock falls after Amazon launches GLP-1 program

Hims & Hers Health stock falls after Amazon launches GLP-1 program…

Hims & Hers Health stock falls after Amazon launches GLP-1 program

Hims & Hers Health stock falls after Amazon launches GLP-1 program…

Hims & Hers (HIMS) Stock Up 49% in Five Days on FDA Peptide Review and Novo Nordisk Deal

Hims & Hers (HIMS) stock surged 49% in five days after the FDA signaled peptide regulatory relief and a Novo…

Is Hims and Hers Stock Back on the Larger Uptrend as Peptide Push and Weight-Loss Demand Boost Sentiment?

Hims & Hers Health is staging a strong comeback as optimism around weight-loss drugs and regulatory changes lifts investor sentiment.…

Hims & Hers Health Inc (HIMS) Stock Up 7.6% and Still Undervalued -- GF Score: 81/100

On April 20, 2026, Hims & Hers Health Inc (HIMS) shares rose 7.6% today, bringing the current price to $31.01.…

Hims & Hers CFO Okupe Oluyemi sells $1.46 million in company stock

Hims & Hers CFO Okupe Oluyemi sells $1.46 million in company stock…

Hims & Hers CFO sells 54,927 shares, exercises options

Hims & Hers CFO Oluyemi Okupe sells 54,927 shares and exercises 6,184 stock options at $5.01, all under a Rule…

Hims & Hers Surges Ahead of Earnings as Omnicell Lags in Healthcare Tech Shakeout

Hims & Hers Health shares jumped 8.9% Monday morning, extending a 48.3% weekly gain ahead of its May 11 earnings…

Hims & Hers Health stock price forecast: $28.50–$31.80 range as HIMS climbs 4.68%

Hims & Hers Health trades at $30.17, up 4.68% today after regulatory and earnings news boosts momentum despite overbought signals.…

Why Hims & Hers Health Stock Is Surging Monday - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health shares are trading higher on Monday as traders lean into optimism around a potentially friendlier regulatory…

Hims & Hers Rallies 9% as Investors Bet Big on Peptide Pipeline and Novo Nordisk Deal

Hims & Hers Health (NYSE:HIMS) shares are up 9% in early trading Monday, climbing from $28.82 to $31 and change…

Hims & Hers Rallies 9% as Investors Bet Big on Peptide Pipeline and Novo Nordisk Deal

Hims & Hers Health (NYSE:HIMS) shares are up 9% in early trading Monday, climbing from $28.82 to $31 and change…

Hims & Hers: the essential HIMS stock update

Hims & Hers Health stock jumped 48% in a week, driven by FDA peptide rule changes, a renewed Novo Nordisk…

Hims & Hers Health Aktie: Neue Wachstumschance nach FDA-Signal

Boston, MA (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von Leerink Partners:Leerink-Analyst Michael Cherny werte die Ankündigung von Gesundheitsminister Robert Kennedy,…

Why Hims & Hers Health Stock Won’t Stop Climbing

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers: Wie der Sommer das Geschäft massiv ankurbelt

Hims & Hers Health ist ein US-amerikanisches Telemedizin-Unternehmen, das sich auf digitale Gesundheitslösungen rund um Themen wie Haarausfall, Hautpflege, sexuelle Gesundheit und zunehmend…

Hims shares rise as US moves to ease peptide regulations

Hims & Hers stock jumps after US regulators signal easing peptide restrictions, opening new opportunities in telehealth and wellness treatments.…

Hims & Hers: Institutional Backing Meets Insider Selling Amid Regulatory Catalyst

Hims & Hers navigates insider selling and strong institutional backing. Strong revenue growth meets…

Hims & Hers (HIMS) Jumps 48% Ahead of Earnings

Hims & Hers saw its share prices jump by 48.3 percent week-on-week as investors positioned portfolios ahead of the results…

Hims & Hers (HIMS) Jumps 48% Ahead of Earnings

Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks With Monster Returns. Hims & Hers saw its…

Hims & Hers: A Critical Week for a Stock Riding a Regulatory Wave

Hims & Hers stock soared 37% on FDA peptide review hopes, but Q1 earnings face headwinds from revenu…

Hims & Hers May Have Just Rewritten Its Entire Business Model!

Hims & Hers Health did not report a surprise quarter, unveil a major product launch, or raise guidance when the…

Healthcare Tech Q4 2025: Revenue Beat, Hims & Hers Growth, and Privia Health Leads

A review of Q4 2025 performance in healthcare tech, highlighting sector revenue beats, Hims & Herss 28.4% growth, and Privia…

Hims & Hers Health, Inc. (NYSE:HIMS) Sees Large Drop in Short Interest

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) was the recipient of a large decrease in short interest…

Is It Time To Reassess Hims & Hers Health (HIMS) After The Recent Share Price Surge

If you are wondering whether Hims & Hers Health at around US$26.99 is still offering value or already pricing in…

HIMS Receives Upgrade Amid Positive Regulatory Outlook

On April 17, 2026, Hims & Hers Health Inc (HIMS) received a Buy rating upgrade from Petri Dish Reports, highlighting…

+7.34% for Hims & Hers Health stock as FDA eyes peptide drug policy change

Hims & Hers Health trades at $28.97, up 7.34% today. Get the latest technicals, trends, and market outlook for HIMS.…

Hims & Hers stock jumps 14% after FDA schedules peptide compounding review

The FDA will convene an outside panel in July to weigh compounding eligibility for 7 peptides, a category Hims &…

Hims & Hers stock rises 14% as FDA schedules peptide compounding review

The U.S. Food and Drug Administration set July 23–24 advisory meetings to evaluate seven peptides for compounding eligibility, a development…

Hims & Hers Health (HIMS) Soars 11.1%: Is Further Upside Left in the Stock?

Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average.…

Hims And Hers Peptide Review Adds New Angle To Valuation Debate

U.S. health authorities are reviewing peptide regulations, with a key FDA compounding advisory meeting scheduled for July.HHS communications, including comments…